Introduction Most drugs do not achieve their projected revenue forecasts. While revenue strategies for pharmacy dispensed drugs (those covered under pharmacy benefits) are well socialized, clinically administered drugs (those covered under medical benefits) face unique, largely unaddressed challenges associated with the nuances of medical claims processing. Finding, analyzing, and acting on critical knowledge, from pre- launch to post-market, improves performance. A healthcare data analytics platform that provides this requires three assets: de-identified medical claims/remittances/SDoH data, a user-friendly drug commercialization intelligence platform, and built-in systemic compliance monitoring.

Join for free to read